|
|
Volumn 301, Issue 15, 2009, Pages 1521-1525
|
|
Scientists see hope, peril in trials of islet transplantation for diabetes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN;
DACLIZUMAB;
ETANERCEPT;
EVEROLIMUS;
INSULIN;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
RITUXIMAB;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DIABETES MELLITUS;
GLYCEMIC CONTROL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LOW DRUG DOSE;
NONHUMAN;
PANCREAS ISLET CELL;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
NOTE;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS;
HUMANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
|
|
EID: 64749104350
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2009.475 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|